Mark A. Velleca
CIK 1706847 · PRESIDENT & CEO · last filed 2026-01-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$212.7K
Companies
2
Total Filings
45
Lifetime Open-Market Net
-$8.88M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDTX | PRESIDENT & CEO | 121,522 | $1.75 | $212.7K | $0 | 13 | 2026-01-23 |
| G1 Therapeutics, Inc. (GTHX) Delisted | Director | 173,286 | $7.15 | $1.24M | -$8.88M | 32 | 2023-08-10 |
Recent Filings · Page 5 of 5
45 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-16 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$258.6K | EDGAR |
| 2018-02-16 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$122.1K | EDGAR |
| 2018-01-17 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$144.5K | EDGAR |
| 2018-01-04 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-20 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$122.2K | EDGAR |
Showing 41–45 of 45
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.